Summary
Writing in the BMJ, Kinnon MacKinnon, Pablo Expósito-Campos and W Ariel Gould argue that people who stop or reverse a gender transition have been ignored by research and care, partly because the topic has become political. Drawing on a few small studies of volunteers, they describe detransitioners as varied, but often female and young when they transitioned. Their reasons range from a change in identity and gender distress that didn't go away, to health worries and discrimination. Many have medical and mental health needs that aren't being met. The authors recommend following patients for at least 5 to 10 years and not assuming that people who drop out of studies (over 30% in some) are doing well. It is a sensible research plan, not new evidence. There was no formal search, and some claims rest on news reports or the authors' own studies.
Key findings
- Dette er en analyseartikel, ikke en fuld gennemgang af forskningen: den sammenfatter nogle få tidlige studier og kommer med anbefalinger, uden nye data.
- De citerede studier (for eksempel en onlineundersøgelse af 237 detransitionister, 92 % kvinder, og et canadisk interviewstudie af 28) tyder på, at mange detransitionister var født som kvinder og transitionerede før 25-årsalderen.
- Årsager til detransition omfatter en ændring i identitet, kønslidelse som transition ikke løste, bekymringer om fysisk eller psykisk sundhed, diskrimination og lidelse forårsaget af selve behandlingen (‘omvendt dysfori’).
- Efter detransition beskriver mange vedvarende kønslidelse, fortrydelse, sorg eller blandede følelser, tab af støtte fra LGBTQ+-venner og at undgå læger af frygt for at blive dømt.
- Forfatterne siger, at opfølgning i 1 til 2 år er for kort, fordi detransition normalt sker flere år efter behandlingen. De anbefaler mindst 5 til 10 år.
- De advarer om, at over 30 % af patienterne falder fra i nogle studier af kønsbehandling, og at forskere ikke bør antage, at disse personer stadig identificerer sig som trans eller ikke har yderligere behov.
- De anbefaler at vælge studiegrupper efter den behandling, folk modtog, frem for deres nuværende identitet, at bruge ordene ‘detrans’ og ‘detransition’ og at indbygge ikke-dømmende detransitionsomsorg i kønsydelser.
Abstract
Kinnon MacKinnon and colleagues call for robust, sensitive research to inform comprehensive gender care services for people who detransition
Conclusion
Rigorous and nuanced detransition research is indispensable. Investigating the experiences of people who detransition will provide a better understanding of the development of gender identity, as well as all health and psychosocial outcomes following gender care. This aligns with priorities identified by trans health experts. Unfortunately, ongoing debates and politicisation of gender care have resulted in the depiction of trans and detrans people as completely distinct groups with divergent needs and experiences, and who are doomed to conflict. However, we believe that trans and detrans people are more similar than different, and that detransition research holds value for advancing the healthcare of all those who transition, and for responsibly moving gender care research and practice forward.